Using everyday drugs to treat stroke complications

The PRECIOUS trial is a Horizon 2020 funded research project that started in June 2015.

In the first few days after stroke, about half of the patients have complications, including:

  • infections
  • fever
  • swallowing problems.

These complications are strongly associated with a higher risk of death or future disability.

PRECIOUS is a large clinical trial, with 3,800 patients aged 66 years or older with acute stroke, that assesses the impact of pharmacological prevention of these frequent complications.

PRECIOUS uses cheap, off-the-shelf medications that are simple, safe and readily available.

It has the potential to lead to an annual reduction of over 25,000 elderly Europeans prematurely dying or being left dependent as a result of stroke.

Contact our European Research Manager via for more information.